Dai Kishida

Update on prevention, diagnosis, and treatment of chronic hepatitis B: AASLD 2018 hepatitis B guidance

Rheumatoid arthritis

Hepatitis B virus reactivation associated with antirheumatic therapy: Risk and prophylaxis recommendations

Targeting Interleukin-6: All the Way to Treat Autoimmune and Inflammatory Diseases

Familial Mediterranean Fever: Recent Developments in Pathogenesis and New Recommendations for Management

IL-6 in Inflammation, Immunity, and Disease

Risk of hepatitis B virus reactivation in rheumatoid arthritis patients undergoing biologic treatment: Extending perspective from old to newer drugs

Reactivation of hepatitis B virus during targeted therapies for cancer and immune-mediated disorders

Guidelines on the Use of Therapeutic Apheresis in Clinical Practice – Evidence‐Based Approach from the Writing Committee of the American Society for Apheresis: The Eighth Special Issue

EASL 2017 Clinical Practice Guidelines on the management of hepatitis B virus infection

Genotype-phenotype correlation in Japanese patients with familial Mediterranean fever: differences in genotype and clinical features between Japanese and Mediterranean populations

Successful tocilizumab treatment in a patient with adult-onset Still’s disease complicated by chronic active hepatitis B and amyloid A amyloidosis

Successful tocilizumab treatment in a patient with adult-onset Still’s disease complicated by chronic active hepatitis B and amyloid A amyloidosis